PATH vs SOLV
Uipath Inc (PATH) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the PATH and SOLV stock pages for the full models.
Not investment advice.